Affiliation:
1. I.M. Sechenov First Moscow State Medical University (Sechenov University)
Abstract
Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease. Thus, the evaluation of the safety and efficacy of other antimycotic drugs becomes an important task in the fight against recurrent genital candidiasis. The article presents the data of international and domestic studies on the possibilities of using sertaconazole in the therapy of vulvovaginal candidiasis.
Reference23 articles.
1. Sobel J.D. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067.
2. Achkar J.M., Fries B.C. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010 Apr;23(2):253-273. doi: 10.1128/CMR.00076-09.
3. Bayramova G.R. Chronic recurrent vulvovaginal candidiasis: principles of diagnosis and therapeutic possibilities. Akusherstvo i Ginekologiya = Obstetrics and Gynecology. 2008;(6):64-66. (In Russ.) Available at: http://www.fesmu.ru/elib/Article.aspx?id=193748.
4. Workowski K.A., Bolan G.A. Sexually Transmitted Diseases Treatment Guidelines. MMWR Recomm Rep. 2015;64(RR-03):1-137. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26042815.
5. Sobel J.D. Vulvovaginal candidosis. Lancet. 2007;369:1961–1971. doi: 10.1016/S01406736(07)60917-9.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献